
Metmik P 1mg/500mg/15mg Tablet
Marketer
Mikayla Life Sciences Pvt. Ltd.
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metmik P 1mg/500mg/15mg Tablet
Glucotrim Trio 1mg/500mg/15mg tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Always follow your physician's prescribed dosage and regimen for Glucotrim Trio. Take it with food to prevent gastrointestinal distress. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is essential. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function will be assessed before treatment begins. Limit alcohol consumption, as it may heighten the risk of side effects.
Uses of Metmik P 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Metmik P 1mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Metmik P 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
Common Side effects of Metmik P 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metmik P 1mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metmik P 1mg/500mg/15mg tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Metmik P 1mg/500mg/15mg Tablet works:
Metmik P 1mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metmik P 1mg/500mg/15mg tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Using Metmik P 1mg/500mg/15mg tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Metmik P 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Metmik P 1mg/500mg/15mg tablets, potentially requiring dosage modification. Physician consultation is recommended. The use of Metmik P 1mg/500mg/15mg tablets is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Metmik P 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Metmik P 1mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metmik P 1mg/500mg/15mg Tablet :
Should you forget to take a Metmik P 1mg/500mg/15mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Metmik P 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Medication |
